Clinical Trial Update: HER2-positive Breast Cancer Project Initiated by Investigators [Phase 2]

View source ↗

Summary

Investigator-initiated Phase 2 clinical trial update for HER2-positive breast cancer involving Fudan University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN